These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26402096)

  • 21. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.
    Musunuri S; Khoonsari PE; Mikus M; Wetterhall M; Häggmark-Mänberg A; Lannfelt L; Erlandsson A; Bergquist J; Ingelsson M; Shevchenko G; Nilsson P; Kultima K
    J Alzheimers Dis; 2016 Oct; 54(4):1671-1686. PubMed ID: 27636840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
    Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
    Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of endoplasmic reticulum in amyloid precursor protein processing and trafficking: implications for Alzheimer's disease.
    Plácido AI; Pereira CM; Duarte AI; Candeias E; Correia SC; Santos RX; Carvalho C; Cardoso S; Oliveira CR; Moreira PI
    Biochim Biophys Acta; 2014 Sep; 1842(9):1444-53. PubMed ID: 24832819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
    Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
    Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of inhibitors of apoptosis proteins in Alzheimer's disease brains.
    Christie LA; Su JH; Tu CH; Dick MC; Zhou J; Cotman CW
    Neurobiol Dis; 2007 Apr; 26(1):165-73. PubMed ID: 17292615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains.
    Pei JJ; Gong CX; Iqbal K; Grundke-Iqbal I; Wu QL; Winblad B; Cowburn RF
    J Neural Transm (Vienna); 1998; 105(1):69-83. PubMed ID: 9588762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of endoplasmic reticulum stress in tauopathy.
    Sakagami Y; Kudo T; Tanimukai H; Kanayama D; Omi T; Horiguchi K; Okochi M; Imaizumi K; Takeda M
    Biochem Biophys Res Commun; 2013 Jan; 430(2):500-4. PubMed ID: 23237806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease.
    Soejima N; Ohyagi Y; Nakamura N; Himeno E; Iinuma KM; Sakae N; Yamasaki R; Tabira T; Murakami K; Irie K; Kinoshita N; LaFerla FM; Kiyohara Y; Iwaki T; Kira J
    Curr Alzheimer Res; 2013 Jan; 10(1):11-20. PubMed ID: 22950910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased association between rough endoplasmic reticulum membranes and mitochondria in transgenic mice that express P301L tau.
    Perreault S; Bousquet O; Lauzon M; Paiement J; Leclerc N
    J Neuropathol Exp Neurol; 2009 May; 68(5):503-14. PubMed ID: 19525898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the novel protein P9TLDR (temporal lobe down-regulated) with a brain-site-specific gene expression modality in Alzheimer's disease brain.
    Yokota T; Akatsu H; Miyauchi T; Heese K
    FEBS Lett; 2012 Dec; 586(24):4357-61. PubMed ID: 23159938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
    Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H
    Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
    Boutajangout A; Boom A; Leroy K; Brion JP
    FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Region-specific expression of tau, amyloid-β protein precursor, and synaptic proteins at physiological condition or under endoplasmic reticulum stress in rats.
    Lin L; Yang SS; Chu J; Wang L; Ning LN; Zhang T; Jiang Q; Tian Q; Wang JZ
    J Alzheimers Dis; 2014; 41(4):1149-63. PubMed ID: 24787918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The unfolded protein response is activated in Alzheimer's disease.
    Hoozemans JJ; Veerhuis R; Van Haastert ES; Rozemuller JM; Baas F; Eikelenboom P; Scheper W
    Acta Neuropathol; 2005 Aug; 110(2):165-72. PubMed ID: 15973543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.